22.09
Trastuzumab and Nivolumab Combo Shows Encouraging Response in HER2-Positive Biliary Tract Cancer
A phase 1b/2 trial published in Nature Medicine reports that first-line treatment with trastuzumab plus nivolumab, gemcitabine, and cisplatin produced encouraging clinical response rates in…